XML 63 R21.htm IDEA: XBRL DOCUMENT

15. Warrants and Options

12 Months Ended

Dec. 31, 2014

Other Liabilities Disclosure [Abstract]

15. Warrants and Options

15. Warrants and Options

Warrants

On December 24, 2013 the Company issued 4,500,000 warrants, expiring on January 19, 2016, exercisable at $0.15.

On January 17, 2014 as part of the sale of units of warrants and shares, the Company issued 1,500,000 warrants, expiring on December 19, 2016, exercisable at $0.15.

Options

On April 1, 2012, the Company granted 3,600,000 options to the Director of Aftercare at an exercise price of $0.20. The intrinsic value of these options was recorded as an expense, at the rate of $312,248 per quarter over the life of the options, as they vested. The 3,600,000 options were terminated on May 5, 2014 upon the sale of Aftercare.

On August 15, 2014, the Company granted 300,000 options to the President of its Investor Relations firm at an exercise price of $0.00333. The $34,418 intrinsic value of these options was recorded as an expense on that date.

On November 1, 2014, the Company granted 480,000 options to its Chief Financial Officer. at an exercise price of $0.12. The $20,844 intrinsic value of these options was recorded as an expense on that date.

				Number of Options and Warrants				Weighted Average Exercise Price Per Share

	Outstanding at December 31, 2012				3,600,000			$	0.200

	Granted				1,500,000				0.150
	Cancelled/forfeited				—				—
	Expired				—				—
	Exercised				—
	Outstanding at December 31, 2013				5,100,000			$	0.185

	Granted				5,280,000				0.139
	Cancelled/forfeited				—				—
	Expired				(3,600,000	)			(0.20	)
	Exercised				—				—
	Outstanding at December 31, 2014				6,780,000			$	0.139

The entire disclosure for freestanding option contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock. Includes disclosure on the strike price and the number of shares to which the contract is indexed, the settlement date or dates of the contract, and the issuer's accounting for the contract. If the terms of the contract provide settlement alternatives, those settlement alternatives are disclosed, including who controls the settlement alternatives, and the maximum number of shares that could be required to be issued, to net share settle the contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that could be required to be issued, the fact that a potentially infinite number of shares that may be required to be issued to settle the contract is disclosed. Disclosure also includes the contract's current fair value for each settlement alternative and how changes in the price of the issuer's equity instruments affect those settlement amounts.

+ References+ Details